These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34171004)

  • 1. Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with
    Hibi A; Mizuguchi K; Yoneyama A; Kasugai T; Kamiya K; Kamiya K; Ito C; Kominato S; Miura T; Koyama K
    Ren Replace Ther; 2018; 4(1):16. PubMed ID: 34171004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
    Fujiwara Y; Ito K; Takamura A; Nagata K
    J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
    Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L
    Front Immunol; 2019; 10():1489. PubMed ID: 31316523
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
    Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K
    J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: A case of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls.
    Sato H; Kanno A; Sato M; Endo A; Ito H; Ohara T; Shirota Y; Sumitomo K; Mori T; Furukawa K
    Front Immunol; 2023; 14():1266187. PubMed ID: 37901232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q; Zhang Y; Zhou G; Zhu J
    BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
    Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
    Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
    Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
    BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
    Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
    Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise Treatment for TAFRO Syndrome.
    Ide M; Yokoyama T; Ishikawa M; Kojima K
    J Med Cases; 2023 Nov; 14(11):369-377. PubMed ID: 38029058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal histology in a patient with TAFRO syndrome: a case report.
    Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
    Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
    Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
    Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
    Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
    Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
    Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.
    Tanaka M; Tsujimoto H; Yamamoto K; Shimoda S; Oka K; Takeoka H
    Medicine (Baltimore); 2017 Oct; 96(40):e8216. PubMed ID: 28984775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
    Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.